telehealth glp-1 treatments platforms MEDVi is showing what a new kind of company can look like A platform selling weight-loss drugs directly to consumers Built in ~2 months with ~20K Now tracking toward $1.8B GLP-1 Telehealth Platforms: Clinical Comparison

Zepbound should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist medicines, and it has not been studied in patients with a history of pancreatitis, or with severe gastrointestinal disease, including severe gastroparesis

It still needs proteinand you dont want it to break down your muscle tissue to get it

-Prescription medication support including best in class medications and more

The growing availability of GLP-1 receptor agonists reflects a shift in obesity management from focusing solely on willpower and calorie restriction towards recognising obesity as a chronic medical condition influenced by hormonal, metabolic, genetic and environmental factors